Acute Graft-versus-Host Disease Biology, Prevention and Therapy
By R. Zeiser, B. Blazar. New England Journal of Medicine, 2017
961 citations recorded by the source corpus.
When T cells from a bone marrow donor begin to attack the host within 3 months after hematopoietic-cell transplantation, acute graft-versus-host disease results. The disease mainly affects the skin, liver, and gastrointestinal tract and is treated with immunosuppressive drugs.
Subfields: Hematology, Immunology
View Paper: https://www.semanticscholar.org/paper/5824045a16c755b7a8132d39c4751815d59c215f